Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-02 Christmas Patrick J. Chief Legal Officer Option exercise +10,000 $12.10 $121K 26,372
2021-02-02 Christmas Patrick J. Chief Legal Officer Sale −9,500 $44.77 $425K 16,872
2021-02-02 Christmas Patrick J. Chief Legal Officer Sale −500 $45.13 $23K 16,372
2021-02-02 Christmas Patrick J. Chief Legal Officer Option exercise · Employee Stock Option (Right to Buy) −10,000 12,431
2021-01-25 Mills Kenneth T. President and CEO Option exercise +6,500 $0.85 $6K 287,484
2021-01-25 Mills Kenneth T. President and CEO Sale −315 $42.64 $13K 287,169
2021-01-25 Mills Kenneth T. President and CEO Sale −974 $44.05 $43K 286,195
2021-01-25 Mills Kenneth T. President and CEO Sale −5,211 $44.99 $234K 280,984
2021-01-25 Mills Kenneth T. President and CEO Option exercise · Employee Stock Option (Right to Buy) −6,500 41,170
2021-01-15 Vasista Vittal Chief Financial Officer Sale −252 $50.04 $13K 113,640
2021-01-14 Simpson Curran Chief Oper. & Tech. Officer Option exercise +1,240 $19.50 $24K 18,988
2021-01-14 Simpson Curran Chief Oper. & Tech. Officer Option exercise +10,372 $35.80 $371K 29,360
2021-01-14 Simpson Curran Chief Oper. & Tech. Officer Sale −11,612 $50.01 $581K 17,748
2021-01-14 Simpson Curran Chief Oper. & Tech. Officer Option exercise · Stock Option (Right to Buy) −1,240 0
2021-01-14 Simpson Curran Chief Oper. & Tech. Officer Option exercise · Stock Option (Right to Buy) −10,372 17,128
2021-01-14 Vasista Vittal Chief Financial Officer Sale −11,093 $50.03 $555K 113,892
2021-01-12 Simpson Curran Chief Oper. & Tech. Officer Option exercise +1,700 $19.50 $33K 19,448
2021-01-12 Simpson Curran Chief Oper. & Tech. Officer Sale −1,700 $50.03 $85K 17,748
2021-01-12 Simpson Curran Chief Oper. & Tech. Officer Option exercise · Stock Option (Right to Buy) −1,700 1,240
2021-01-12 Vasista Vittal Chief Financial Officer Sale −4,200 $50.01 $210K 124,985

Page 18 of 25 · 494 trades